XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value
The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy:
September 30, 2022December 31, 2021
(in millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Available-for-sale debt securities:
U.S. treasury securities$448 $— $— $448 $407 $— $— $407 
U.S. government agencies securities— 19 — 19 — — 
Non-U.S. government securities— 44 — 44 — 50 — 50 
Certificates of deposit— 65 — 65 — 249 — 249 
Corporate debt securities— 1,367 — 1,367 — 1,363 — 1,363 
Residential mortgage and asset-backed securities— 347 — 347 — 424 — 424 
Equity securities:
Money market funds3,316 — — 3,316 3,661 — — 3,661 
Equity investment in Galapagos NV (“Galapagos”)703 — — 703 931 — — 931 
Equity investment in Arcus Biosciences, Inc. (“Arcus”)361 — — 361 559 — — 559 
Other publicly traded equity securities205 — — 205 331 — — 331 
Deferred compensation plan208 — — 208 261 — — 261 
Foreign currency derivative contracts— 242 — 242 — 80 — 80 
Total$5,242 $2,084 $— $7,325 $6,150 $2,170 $— $8,320 
Liabilities:
Liability for MYR GmbH (“MYR”) contingent consideration$— $— $249 $249 $— $— $317 $317 
Deferred compensation plan208 — — 208 261 — — 261 
Foreign currency derivative contracts— — — — 
Total$208 $$249 $458 $261 $$317 $583 
Summary of Change in Fair Value of Contingent Consideration
The following table summarizes the change in fair value of our contingent consideration:
Three Months EndedNine Months Ended
September 30,September 30,
(in millions)2022202120222021
Beginning balance$306 $334 $317 $— 
Additions— — — 341 
Changes in valuation assumptions(30)— (19)— 
Effect of foreign exchange remeasurement(27)(7)(49)(13)
Ending balance
$249 $328 $249 $328